20 related articles for article (PubMed ID: 37827639)
1. A SARS-CoV-2 M
Han L; Wang B; Sun K; Sitara M; Li M; Wang P; Chen N; Yu XA; Tian J
Analyst; 2024 Jun; 149(13):3585-3595. PubMed ID: 38767148
[TBL] [Abstract][Full Text] [Related]
2. A universal method for profiling and characterization of oligosaccharides in traditional Chinese medicines.
Liu Y; Song J; Liu S; Nan Y; Zheng W; Pang X; Chen X; Liang H; Zhang J; Ma B
J Pharm Biomed Anal; 2024 Jul; 244():116129. PubMed ID: 38579408
[TBL] [Abstract][Full Text] [Related]
3. Xuebijing injection and its bioactive components alleviate nephrotic syndrome by inhibiting podocyte inflammatory injury.
Yuan S; Cao Y; Jiang J; Chen J; Huang X; Li X; Zhou J; Zhou Y; Zhou J
Eur J Pharm Sci; 2024 May; 196():106759. PubMed ID: 38570053
[TBL] [Abstract][Full Text] [Related]
4. Thrombin-targeted screening of anticoagulant active components from Polygonum amplexicaule D. Don var. sinense Forb by affinity ultrafiltration coupled with UPLC-Q-TOF-MS.
Huang S; He X; Huang C; He W; Zhao H; Dai J; Xu G
Phytochem Anal; 2024 Mar; ():. PubMed ID: 38500381
[TBL] [Abstract][Full Text] [Related]
5. UHPLC-PDA-Q-TOF-MS-α-amylase-FLD activity detection system and molecular docking.
Zhu Y; Yang Y; Tang Z; Xue T; Chen S; Yang H; Su Z; Xu H
Phytochem Anal; 2024 May; ():. PubMed ID: 38741027
[TBL] [Abstract][Full Text] [Related]
6. Antiseptic Activity of Ethnomedicinal Xuebijing Revealed by the Metabolomics Analysis Using UHPLC-Q-Orbitrap HRMS.
Zuo L; Zhou L; Xu T; Li Z; Liu L; Shi Y; Kang J; Gao G; Du S; Sun Z; Zhang X
Front Pharmacol; 2018; 9():300. PubMed ID: 29651245
[TBL] [Abstract][Full Text] [Related]
7. Rapid determination of 30 bioactive constituents in XueBiJing injection using ultra high performance liquid chromatography-high resolution hybrid quadrupole-orbitrap mass spectrometry coupled with principal component analysis.
Zuo L; Sun Z; Hu Y; Sun Y; Xue W; Zhou L; Zhang J; Bao X; Zhu Z; Suo G; Zhang X
J Pharm Biomed Anal; 2017 Apr; 137():220-228. PubMed ID: 28147306
[TBL] [Abstract][Full Text] [Related]
8. An integration strategy combined progressive multivariate statistics with anticoagulant activity evaluation for screening anticoagulant quality markers in Chinese patent medicine.
Du KZ; Cui Y; Chen S; Yang R; Shang Y; Wang C; Yan Y; Li J; Chang YX
J Ethnopharmacol; 2022 Apr; 287():114964. PubMed ID: 34990765
[TBL] [Abstract][Full Text] [Related]
9. Identification of NF-κB Inhibitors in Xuebijing injection for sepsis treatment based on bioactivity-integrated UPLC-Q/TOF.
Jiang M; Zhou M; Han Y; Xing L; Zhao H; Dong L; Bai G; Luo G
J Ethnopharmacol; 2013 May; 147(2):426-33. PubMed ID: 23524166
[TBL] [Abstract][Full Text] [Related]
10. An activity-integrated strategy involving ultra-high-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry and fraction collector for rapid screening and characterization of the α-glucosidase inhibitors in Coptis chinensis Franch. (Huanglian).
Ge AH; Bai Y; Li J; Liu J; He J; Liu EW; Zhang P; Zhang BL; Gao XM; Chang YX
J Pharm Biomed Anal; 2014 Nov; 100():79-87. PubMed ID: 25137652
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination and pharmacokinetic study of twelve bioactive compounds in rat plasma after intravenous administration of Xuebijing injection by UHPLC-Q-Orbitrap HRMS.
Zuo L; Zhong Q; Wang Z; Sun Z; Zhou L; Li Z; Xu T; Shi Y; Tang J; Du S; Zhang X
J Pharm Biomed Anal; 2017 Nov; 146():347-353. PubMed ID: 28918324
[TBL] [Abstract][Full Text] [Related]
12. An aggregation-induced emission sensor combined with UHPLC-Q-TOF/MS for fast identification of anticoagulant active ingredients from traditional Chinese medicine.
Li Z; Wang B; Sun K; Yin G; Wang P; Yu XA; Zhang C; Tian J
Anal Chim Acta; 2023 Oct; 1279():341799. PubMed ID: 37827639
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
